A detailed history of Integrated Advisors Network LLC transactions in Biogen Inc. stock. As of the latest transaction made, Integrated Advisors Network LLC holds 1,967 shares of BIIB stock, worth $341,844. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,967
Previous 2,502 21.38%
Holding current value
$341,844
Previous $580,000 34.31%
% of portfolio
0.02%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$189.07 - $236.8 $101,152 - $126,688
-535 Reduced 21.38%
1,967 $381,000
Q2 2024

Aug 09, 2024

BUY
$190.52 - $236.72 $159,274 - $197,897
836 Added 50.18%
2,502 $580,000
Q1 2024

May 03, 2024

BUY
$212.02 - $267.71 $183,185 - $231,301
864 Added 107.73%
1,666 $359,000
Q4 2023

Feb 26, 2024

SELL
$222.59 - $267.94 $72,564 - $87,348
-326 Reduced 28.9%
802 $207,000
Q3 2023

Nov 16, 2023

BUY
$253.3 - $285.89 $67,377 - $76,046
266 Added 30.86%
1,128 $289,000
Q2 2023

Jul 14, 2023

BUY
$275.25 - $318.06 $19,818 - $22,900
72 Added 9.11%
862 $245,000
Q1 2023

May 05, 2023

BUY
$256.56 - $292.34 $202,682 - $230,948
790 New
790 $219,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $162,342 - $208,633
-725 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $1,131 - $1,476
4 Added 0.55%
725 $205,000
Q2 2021

Aug 06, 2021

BUY
$259.0 - $414.71 $186,739 - $299,005
721 New
721 $250,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $171,052 - $257,476
-724 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$264.77 - $305.71 $12,708 - $14,674
-48 Reduced 6.22%
724 $205,000
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $24,831 - $32,884
96 Added 14.2%
772 $206,000
Q1 2020

May 06, 2020

SELL
$268.85 - $341.04 $18,281 - $23,190
-68 Reduced 9.14%
676 $214,000
Q4 2019

Feb 06, 2020

BUY
$220.06 - $304.07 $163,724 - $226,228
744 New
744 $221,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.